NCT04532463View on ClinicalTrials.gov

Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal Meningitis

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

March 30, 2022

Study Completion Date

April 20, 2022

Conditions
Cryptococcal Meningitis
Interventions
DRUG

Amphotericin B 1 mg/kg 1 week & Flucytosine 100 mg/kg 1 week followed by Fluconazole 1200 mg/day 1 week

To study the clinical effectiveness and safety of amphotericin B with flucytosine-fluconazole therapy for cryptococcal meningitis in patients with HIV infection.

Trial Locations (1)

11181

Specialist hospital Mingalardon,Thakeyta and Waibargi,Yangon General Hospital,Insein General Hospital, North Oakalapa General and Teaching Hosptial, Yangon

All Listed Sponsors
lead

University of Pharmacy, Yangon

OTHER

NCT04532463 - Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal Meningitis | Biotech Hunter | Biotech Hunter